help, aid


The agency approved Scenesse, a subcutaneous implant for treating the rare disorder erythropoietic protoporphyria. The drug is the first FDA-approved treatment for EPP.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here